4.5 Letter

The limitation of flowcytometry is ignored in the assessment of antimitochondrial antibodies in rheumatoid arthritis: comment on the article by Moore et al Reply

Related references

Note: Only part of the references are listed.
Article Immunology

Role of mitochondria in the myopathy of juvenile dermatomyositis and implications for skeletal muscle calcinosis

Bhargavi Duvvuri et al.

Summary: This study elucidates the mechanisms contributing to skeletal muscle calcinosis in patients with juvenile dermatomyositis. It identifies mitochondrial markers and anti-mitochondrial antibodies (AMAs) as predictors of calcinosis. The study also shows that interferon-alpha exacerbates mitochondrial calcification of human skeletal muscle cells via the generation of mitochondrial reactive oxygen species (mtROS). Targeting mtROS and/or upstream inducers, such as inflammation, may alleviate mitochondrial dysfunction and mitigate calcinosis. AMAs have the potential to identify patients with juvenile dermatomyositis at risk for developing calcinosis.

JOURNAL OF AUTOIMMUNITY (2023)

Article Rheumatology

Identification of Mitofusin 1 and Complement Component 1q Subcomponent Binding Protein as Mitochondrial Targets in Systemic Lupus Erythematosus

Yann L. C. Becker et al.

Summary: In this study, the mitochondrial protein repertoire recognized by antimitochondrial antibodies (AMAs) in SLE patients was characterized. The study found that autoantibodies can recognize secreted and/or surface proteins of mitochondrial origin. Profiling of the AMA repertoire in large prospective cohorts may improve our knowledge of mitochondrial biomarkers and their usefulness for patient stratification.

ARTHRITIS & RHEUMATOLOGY (2022)

Article Multidisciplinary Sciences

Single organelle analysis to characterize mitochondrial function and crosstalk during viral infection

Annika Schneider et al.

SCIENTIFIC REPORTS (2019)